[MCK-4065MM] McKesson™ Conventional Standard Laryngoscope Handle
[MCK-S662GX] McKesson™ Nylon Sutures Size 4-0 | 18" | C-13 | 3/8 Circle Black

Zynrelef™ (Bupivacaine / Meloxicam) 14mL | 400 - 12mg Injectable SDV

MCK-47426030102
https://www.613med.com/web/image/product.template/12272/image_1920?unique=c847a40

Heron Therapeutics

744.50 744.5 USD 744.50 (Per unit price)

875.88

Not Available For Sale

  • Brand
  • Type
  • Volume
  • Additional
  • Manufacturer
  • Active Ingredients

This combination does not exist.

  • RX License on File Required to Order

    Detail
Anesthetics

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Zynrelef is a long-acting, extended-release injectable medication designed to manage postoperative pain. Containing 400 mg of the active ingredient, this single-dose vial (SDV) delivers targeted pain relief directly at the surgical site, reducing the need for systemic opioids and enhancing patient comfort during recovery.

Key Features:

  • Active Ingredient: Contains 400 mg of bupivacaine and meloxicam in a proprietary extended-release formulation.
  • Volume: Each vial holds 20 ml of the injectable solution, sufficient for single-use application.
  • Extended Release: Formulated to provide sustained pain relief for up to 72 hours post-surgery.
  • Single-Dose Vial: Ensures precise dosing and minimizes the risk of contamination.
  • Local Application: Administered directly at the surgical site to target pain where it originates.

Applications:

  • Postoperative Pain Management: Ideal for managing pain following surgical procedures, especially those involving soft tissues.
  • Orthopedic Surgeries: Frequently used in procedures like total knee arthroplasty, hip replacement, and shoulder surgeries.
  • General Surgeries: Applicable in a wide range of surgeries including abdominal, thoracic, and other soft tissue operations.

Advantages:

  • Reduced Opioid Use: Provides effective pain relief while minimizing or eliminating the need for systemic opioids.
  • Sustained Pain Relief: Offers up to 72 hours of pain control, improving patient comfort and potentially reducing hospital stays.
  • Targeted Action: Localized delivery at the surgical site helps control pain more effectively with fewer systemic side effects.
  • Convenient Administration: Single-dose vial format simplifies preparation and administration for healthcare professionals.
  • Enhanced Recovery: Facilitates quicker patient mobilization and rehabilitation post-surgery due to effective pain control.

Packaging:

  • Quantity: Sold individually (1 EA), allowing for precise inventory management and tailored ordering based on surgical volume.
  • Sterile Packaging: Each vial is individually packaged to maintain sterility and ensure safety until the point of use.



Product Image
Zynrelef™ (Bupivacaine / Meloxicam) 14mL | 400 - 12mg Injectable SDV

Not Available For Sale